Trialli is the first decentralized clinical trial platform purpose-built for substance use disorder research. AI imports your protocol, captures participant responses by voice, and runs your SUD trial — so coordinators focus on science instead of transcription.
Every existing DCT platform was designed for oncology and pharmacology trials in non-stigmatized conditions. None of them understands SUD.
SUD trial dropout is the #1 cost driver. Housing instability, stigma, and variable shift work mean participants cannot keep clinic appointments — and existing platforms assume they can.
Study coordinators spend most of their time on structured check-ins, form administration, and protocol reminders — tasks that AI can handle at a fraction of the cost.
Systematic coordinator contact adds 40 days of retention. AI can scale that contact to every participant, every week — without adding headcount.
The NIDA Clinical Trials Network — 16 nodes, hundreds of SUD trials — runs on REDCap. No mobile app. No AI. No voice. Trialli is the purpose-built replacement.
Participants speak their answers instead of typing. The app captures speech on-device, a rule-based matcher handles common cases, and an LLM fallback parses ambiguous transcripts into the structured score the form expects — with confidence scoring. Validated for SUD populations with low digital literacy.
Built-in library of behavioral-health instruments — ISI, BAM, PHQ-9, GAD-7, AUDIT-C, PCL-5, FTND, PROMIS Sleep — and protocol-import logic that recognizes a further dozen by alias (ASI, DAST-10, PSQI, MoCA, etc.). Designed around the community treatment-center workflow that NIDA-CTN sites actually run.
Upload the IRB-approved protocol PDF. The platform extracts the 12 ICH-GCP sections, the visit schedule, eligibility criteria, and the form list — and one click creates the entire EDC structure. Weeks of study-build work compressed into minutes.
| Platform | SUD Focus | Voice AI Assessment | Patient-Facing AI | Community Site Model | Pricing |
|---|---|---|---|---|---|
| Trialli You are here | ✓ Purpose-built | ✓ Full interview | ✓ AI Coordinator | ✓ Native | Per-participant SaaS |
| Medidata Rave | ✗ | ✗ | ✗ | ✗ | $200K–$2M/study |
| Medable | ✗ | ✗ | Investigator only | ✗ | $150K+/study |
| Castor EDC | ✗ | ✗ | ✗ | ✗ | Custom |
| REDCap | ✗ | ✗ | ✗ | ✗ | Free / self-hosted |
| ObvioHealth | ✗ | ✗ | ✗ | ✗ | Custom |
Source: Competitive analysis conducted March 2026. No major DCT platform has SUD-specific positioning, instruments, or voice AI capability.
SUD trial assessments are 5–9 instruments per visit. Typing on a phone with shaky hands, blurred vision, or low literacy is the wrong burden to place on someone in early recovery. Voice mode removes it.
Available 24/7 in the iOS / Android / Web app. The current question is read aloud via on-device text-to-speech.
Platform speech recognition transcribes the response — iOS Speech Framework, Android Speech Recognizer, or Web Speech API. On-device Whisper available as offline fallback.
A rule-based matcher resolves the common cases instantly. An LLM fallback parses ambiguous transcripts into the structured value the question expects — number, choice, yes/no, or scale.
DataRecord stored with source = AI_ADMINISTERED and the original transcript. 21 CFR Part 11 audit log.
Today's voice mode is one question at a time. Our Phase II SBIR aim builds the full conversational version: the AI conducts the entire ISI or BAM interview turn-by-turn, asks clarifying follow-ups when confidence is low, screens every response in parallel for C-SSRS suicidality signals, and routes flagged sessions to a human coordinator before the participant ever sees the next question.
Draft protocol, configure sites (treatment centers, MAT clinics, residential programs), assign site PIs and coordinators, invite IRB reviewers — all by email. New users get automatic account setup.
Reviewers log in, read the protocol, and approve or reject with comments. No DocuSign. No email threads. Only approved trials can activate enrollment.
Send invitations by email. Participants receive a link to the Trialli app, create an account, and see their invitation. No app store account required for web.
Participants review the full consent document, agree to terms, and sign electronically — drawn or typed signature. Consent status updates in real time for coordinators.
Scheduled forms (ISI, BAM, PROMIS, AUDIT-C…) appear in the patient app with overdue tracking. Participants either tap their answers or switch to voice mode and speak. Phase II adds the AI coordinator that initiates check-ins, detects missed visits, and escalates safety signals before a coordinator has to look.
Review AI-generated assessments, manage flagged items, report adverse events, track compliance — spending time on clinical judgment, not administrative contact.
A full-featured web application for sponsor administrators and site coordinators. Manage trials, review AI-generated assessments, track compliance, report adverse events — from a single dashboard.
A consumer-grade mobile experience — iOS, Android, and web — designed for the realities of SUD populations: low digital literacy, variable schedules, housing instability.
Participants get answers to their trial questions in plain language, grounded in the protocol context. Today the assistant runs on Google Vertex AI's Gemini 2.5 Flash under a HIPAA BAA; a Phase II RAG pipeline will add retrieval over the protocol, consent, and a curated NIDA SUD literature corpus with source citations.
Collect continuous or episodic health data from participants using consumer wearables, native phone health stores, or manual entry. Sleep and actigraphy data map directly to BBTI and insomnia trial outcomes.
health Flutter plugin
Participants speak instead of type. The current question is read aloud via on-device TTS, the participant's response is transcribed locally, and the answer is matched to the question's expected type — number, choice, scale, yes/no. Ambiguous transcripts fall back to an LLM extractor that returns a structured value with a confidence label.
source = AI_ADMINISTERED + full transcriptDRAFT → PENDING → APPROVED → ACTIVE with full audit trail. Multi-site with per-site personnel, IRB approver assignment, sponsor + coordinator role hierarchy.
Participants review, agree, and sign electronically — drawn or typed signatures — right from their phone. Consent status tracked in real time for coordinators.
Structured AE reporting with severity classification and SAE escalation. Built-in C-SSRS safety screen during every AI check-in. ICH E6(R2) GCP-aligned.
iOS, Android, and web. Designed for SUD populations: simple interface, voice-first check-ins, offline form support, and crisis resources always one tap away.
Coordinators today get an AI-assisted dashboard: real-time visit-compliance, AI-extracted protocol structure from PDF, instrument-library matching, and a participant chat assistant. Phase II expands this into a multi-agent backend that handles the participant relationship autonomously.
Configure validated forms (rating scales, single/multi-choice, free text, numeric) with per-form scheduling, overdue tracking, and revision workflows.
Tamper-evident audit log on all critical models. 21 CFR Part 11 electronic signature support. Full trail for AI decisions, coordinator overrides, and data edits.
Per-feature provider routing: Gemini 2.5 (Vertex AI BAA) for protocol import, chat assistant, and close-out; GPT-5 for form generation; GPT-4o-mini for voice answer extraction. Admin can swap providers per slot from the AI-config panel.
iOS Speech Framework, Android Speech Recognizer, Web Speech API as primary; on-device Whisper (ggml-base-q5_1) bundled for offline fallback. Phase II: AWS Transcribe Medical for the multi-turn voice interview path.
Battle-tested Python backend with role-based permissions, full audit logging, and structured output extraction using OpenAI strict JSON mode.
Standalone-component admin portal with Material Design — fast, type-safe, accessible. AOT-compiled for production.
Single codebase across platforms. Native performance. Designed for low-bandwidth and variable connectivity common in SUD participant populations.
Railway today (staging + production), with per-request email-capture middleware for safe E2E testing. 21 CFR Part 11 audit log on every clinical model. AWS migration for PHI-scale + SOC 2 path planned for Phase II.
Trialli is built by a multidisciplinary team at the intersection of addiction medicine, clinical trial operations, and AI engineering — with NIH NIDA funding and Johns Hopkins University collaboration.
Principal Investigator & Lead Engineer
Carina Medical LLC
Placeholder — add bio and institution here.
Co-Investigator
Johns Hopkins University
Placeholder — add bio and institution here.
Role / Institution
Edit marketing/website/index.html — Team section to add members.
We're actively piloting with NIDA-funded trials and NIDA CTN-affiliated sites. Request a demo and we'll walk you through the workflow live: protocol import, voice-first data capture, and the Phase II AI coordinator roadmap.